Advances in Radiation Oncology in Lung Cancer

This is the third, completely updated edition of a comprehensive book in which many of the world’s leading lung cancer specialists discuss the recent advances in the radiation oncology of lung cancer and reflect on the latest research findings in lung cancer and other intrathoracic malignancies. Lung cancer remains the major cancer killer in both sexes worldwide. It is so despite significant progress in recent decades in both diagnostic and treatment approaches. New biological and technological advances in this field are now faster incorporated in the overall decision-making process and are bringing fast and substantial improvements in both survivals and quality of life of lung cancer patients. Optimized patient-oriented approaches are reality of the third decade of this millennium and thoracic oncologists strive towards nothing but seamlessly delivering it in a continuous battle with lung cancer. 

The first three sections of the work cover the basic science of lung cancer, clinical investigations, including histology and staging, and a wide range of fundamental treatment considerations. Current treatment strategies for small cell and non-small cell lung cancer as well as other intrathoracic malignancies are then explained and evaluated in detail, with due attention to novel approaches that promise further improvements in outcome. The various types of treatment-related toxicity are discussed, and quality of life studies and prognostic factors are also considered. After evaluating the latest technological and biological advances, including stereotactic radiotherapy, and particle therapy, the book concludes by thorough consideration of specific aspects of clinical research in lung cancer.

This concise yet comprehensive book is an invaluable resource for radiation oncologists.

Branislav Jeremic, MD, PhD is Radiation Oncologist with 30+ years of experience in oncology. His major focus is clinical research in solid tumors (lung, head and neck, brain, palliation) exploring altered fractionation regimens with or without concurrent chemotherapy. He had designed and executed as PI more than 30 phase II and III clinical trials that helped change clinical practices worldwide and led to more than 240 peer reviewed publications in major journals worldwide. He is the editor of seminal books such as Advances in Radiation Oncology in Lung Cancer and Stereotactic Radiotherapy in Optic Nerve Sheath Meningioma. He is recipient of many leading fellowships such as those provided by the UICC, Japan Society for the Promotion of Science (JSPS) and Alexander von Humboldt Foundation. He is frequent guest lecturer at many conferences and meetings worldwide and visiting professor at major universities worldwide. He is honorary member of many professional societies and bodies and member of the Academy of Sciences of South Africa (ASSAf). Last several years he serves as co-president of the Arab African International Cancer Congress whose meetings are annually held in Cairo, Egypt. His previous clinical and research posts include those in Serbia, USA, Japan, Germany, Canada, South Africa and Georgia. He was also a staff employee of the International Atomic Energy Agency in Vienna, Austria where he shared The Nobel Peace Prize in 2005, together with other employees and then-Director, Mr. M. El-Baradei.